Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, OBESIDADE, SOBREPESO, RECEPTORES DE SUBSTÂNCIAS ENDÓGENAS
ABNT
BOHULA, Erin A. et al. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Lancet, v. 392, n. 10161, p. 2269-2279, 2018Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(18)32328-6. Acesso em: 08 nov. 2024.APA
Bohula, E. A., Scirica, B. M., Inzucchi, S. E., Mcguire, D. K., Keech, A. C., Smith, S. R., et al. (2018). Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Lancet, 392( 10161), 2269-2279. doi:10.1016/S0140-6736(18)32328-6NLM
Bohula EA, Scirica BM, Inzucchi SE, Mcguire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Nicolau JC. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial [Internet]. Lancet. 2018 ; 392( 10161): 2269-2279.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(18)32328-6Vancouver
Bohula EA, Scirica BM, Inzucchi SE, Mcguire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Nicolau JC. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial [Internet]. Lancet. 2018 ; 392( 10161): 2269-2279.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/S0140-6736(18)32328-6